The story isn't _good_, it's just a bit more complicated. The pharma company's trade association published this recently which talks about it in depth: http://

The story isn't _good_, it's just a bit more complicated. The pharma company's trade association published this recently which talks about it in depth: http://www.phrma.org/report/commercially-insured-patients-pay-undiscounted-list-prices-for-one-in-five-brand-prescriptions-accounting-for-half-of-out-of-pocket-spending-on-brand-medicines http://www.phrma.org/report/commercially-insured-patients-pa...